This study is the first study to suggest that LPA antagonists could be a target for treating respiratory diseases of industrial cows, as well as the first report of KA-1002 as a novel LPA antagonist that alleviates LPA-mediated bovine tracheal cell disruption. This evidence concerns the gene LPA and respiratory system disorder.